To understand how activated GR counteracts the ERα signaling pathway and regulates survival of ERα-positive breast cancer cells, we carried out cell proliferation, gene expression, and ChIP assays in ERα- and GR-positive MCF-7 breast cancer cells, in the presence of E2 or Dex, alone or in combination. The gene discussed is NR3C1; the disease is breast cancer.